Institutional Manager · CIK 0001812177
WALLED LAKE PLANNING & WEALTH MANAGEMENT, LLC
WINNETKA, IL · File #028-20278
Latest AUM
$316.3M
Positions
136
Top-10 Concentration
56.9%
Filings
12
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Dec 2025136 pos · $316.3M
- 13F HOLDINGS REPORTQ/E Sep 2025143 pos · $304.6M
- 13F HOLDINGS REPORTQ/E Jun 2025141 pos · $306.5M
- 13F HOLDINGS REPORTQ/E Mar 2025133 pos · $281.6M
- 13F HOLDINGS REPORTQ/E Dec 2024131 pos · $268.7M
- 13F HOLDINGS REPORTQ/E Sep 2024132 pos · $266.3M
- 13F HOLDINGS REPORTQ/E Jun 2024124 pos · $244.9M
- 13F HOLDINGS REPORTQ/E Mar 2024119 pos · $243.7M
- 13F HOLDINGS REPORTQ/E Dec 2023103 pos · $199.6M
- 13F HOLDINGS REPORTQ/E Sep 2023100 pos · $205.5M
- 13F HOLDINGS REPORTQ/E Jun 202387 pos · $191.0M
- 13F HOLDINGS REPORTQ/E Mar 202353 pos · $146.8M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Doubleline Shiller CAPE US Equity | 25861R204 | 841,761 | $27.1M | 9.65% |
| 2 | Pimco Ultra Short Government ETF | 72201R577 | 264,153 | $26.6M | 9.46% |
| 3 | JPMorgan US Quality Factor | 46641Q761 | 355,381 | $22.5M | 7.98% |
| 4 | iShares MSCI USA Min Vol Factor | 46429B697 | 173,103 | $16.3M | 5.80% |
| 5 | Invesco S&P 500 Equal Weight Healthcare | IVZ | 427,644 | $13.6M | 4.84% |
| 6 | Schwab US Dividend Equity ETF | 808524797 | 453,950 | $12.5M | 4.43% |
| 7 | Apple | AAPL | 45,054 | $12.2M | 4.35% |
| 8 | Invesco S&P 500 Equal Weight | IVZ | 61,034 | $11.7M | 4.16% |
| 9 | Invesco S&P 500 Equal Weight Technology | IVZ | 195,072 | $8.9M | 3.16% |
| 10 | Huntington Ingalls | 446413106 | 25,099 | $8.5M | 3.03% |
| 11 | Novartis | NVSEF | 49,632 | $6.8M | 2.43% |
| 12 | Gilead Sciences | GILD | 53,856 | $6.6M | 2.35% |
| 13 | Altria Group | MO | 111,830 | $6.4M | 2.29% |
| 14 | Cisco | CSCO | 78,008 | $6.0M | 2.14% |
| 15 | Lockheed Martin | LMT | 12,265 | $5.9M | 2.11% |
| 16 | GlaxoSmithKline | GLAXF | 119,066 | $5.8M | 2.08% |
| 17 | Dollar General | 256677105 | 41,449 | $5.5M | 1.96% |
| 18 | Merck & Co | MRK | 47,192 | $5.0M | 1.77% |
| 19 | Houlihan Lokey | HLI | 28,000 | $4.9M | 1.73% |
| 20 | Genpact | G | 101,144 | $4.7M | 1.68% |